Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Vierling

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Frontiers of Medicine|March 10, 2015
Autoimmune hepatitisFarhad Sahebjam, John M Vierling
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2003
The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed hostMarius Braun, John M Vierling
Hepatology (Baltimore, Md.)|September 18, 2023
The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough!George Cholankeril, John M Vierling
Clinics in Liver Disease|August 27, 2011
An overview of emerging therapies for the treatment of chronic hepatitis CJawad A Ilyas, John M Vierling
Clinics in Liver Disease|November 30, 2010
HIV infection and the liver: the importance of HCV-HIV coinfection and drug-induced liver injuryShehzad N Merwat, John M Vierling
The Medical Clinics of North America|November 26, 2013
An overview of emerging therapies for the treatment of chronic hepatitis CJawad A Ilyas, John M Vierling
Clinics in Liver Disease|October 5, 2002
Evolving new therapies of autoimmune hepatitisJohn M Vierling, Patricia A Flores
Texas Heart Institute Journal|March 6, 2019
Progress in Immunosuppressive Agents for Solid-Organ TransplantationWynne Qing Zhang, John M Vierling
Seminars in Liver Disease|February 24, 2006
Etiopathogenesis of primary sclerosing cholangitisChristine A O'Mahony, John M Vierling
Clinical Liver Disease|April 18, 2019
Clinical presentation and natural history of autoimmune hepatitisMichael R Lucey, John M Vierling
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Frontiers of Medicine|March 10, 2015
Autoimmune hepatitisFarhad Sahebjam, John M Vierling
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2003
The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed hostMarius Braun, John M Vierling
Hepatology (Baltimore, Md.)|September 18, 2023
The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough!George Cholankeril, John M Vierling
Clinics in Liver Disease|August 27, 2011
An overview of emerging therapies for the treatment of chronic hepatitis CJawad A Ilyas, John M Vierling
Clinics in Liver Disease|November 30, 2010
HIV infection and the liver: the importance of HCV-HIV coinfection and drug-induced liver injuryShehzad N Merwat, John M Vierling
The Medical Clinics of North America|November 26, 2013
An overview of emerging therapies for the treatment of chronic hepatitis CJawad A Ilyas, John M Vierling
Clinics in Liver Disease|October 5, 2002
Evolving new therapies of autoimmune hepatitisJohn M Vierling, Patricia A Flores
Texas Heart Institute Journal|March 6, 2019
Progress in Immunosuppressive Agents for Solid-Organ TransplantationWynne Qing Zhang, John M Vierling
Seminars in Liver Disease|February 24, 2006
Etiopathogenesis of primary sclerosing cholangitisChristine A O'Mahony, John M Vierling
Clinical Liver Disease|April 18, 2019
Clinical presentation and natural history of autoimmune hepatitisMichael R Lucey, John M Vierling
Pageof 15